nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—STAT3—liver cancer	0.822	1	CbGaD
Niclosamide—CYP1A2—Sorafenib—liver cancer	0.0109	0.526	CbGbCtD
Niclosamide—CYP2C9—Sorafenib—liver cancer	0.00978	0.474	CbGbCtD
Niclosamide—Clonazepam—NAT2—liver cancer	0.00141	0.571	CrCbGaD
Niclosamide—Diflunisal—ALB—liver cancer	0.000428	0.174	CrCbGaD
Niclosamide—Clonazepam—CYP2E1—liver cancer	0.000404	0.164	CrCbGaD
Niclosamide—Clonazepam—ALB—liver cancer	0.000222	0.0903	CrCbGaD
Niclosamide—STAT3—Signaling by FGFR in disease—IL6—liver cancer	6.13e-05	0.000396	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—AKT1—liver cancer	6.1e-05	0.000394	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—AKT1—liver cancer	6.07e-05	0.000392	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—GSTM1—liver cancer	6.06e-05	0.000392	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	6.02e-05	0.000389	CbGpPWpGaD
Niclosamide—STAT3—Disease—PSMA4—liver cancer	6.02e-05	0.000389	CbGpPWpGaD
Niclosamide—STAT3—Disease—PSMD10—liver cancer	6.02e-05	0.000389	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—IL6—liver cancer	6e-05	0.000388	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	5.94e-05	0.000384	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TRIO—liver cancer	5.92e-05	0.000382	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—IL6—liver cancer	5.9e-05	0.000381	CbGpPWpGaD
Niclosamide—STAT3—Disease—GOT2—liver cancer	5.86e-05	0.000378	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP2—liver cancer	5.78e-05	0.000373	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—HPGDS—liver cancer	5.74e-05	0.000371	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNA1—liver cancer	5.71e-05	0.000369	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—HRAS—liver cancer	5.68e-05	0.000367	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCR4—liver cancer	5.67e-05	0.000366	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—AKT1—liver cancer	5.66e-05	0.000366	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—AKT1—liver cancer	5.53e-05	0.000358	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP2E1—liver cancer	5.48e-05	0.000354	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	5.44e-05	0.000352	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	5.44e-05	0.000352	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—IL6—liver cancer	5.43e-05	0.000351	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	5.4e-05	0.000349	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	5.32e-05	0.000344	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	5.31e-05	0.000343	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—KRAS—liver cancer	5.22e-05	0.000337	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	5.18e-05	0.000335	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—KRAS—liver cancer	5.14e-05	0.000332	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—RAF1—liver cancer	5.12e-05	0.000331	CbGpPWpGaD
Niclosamide—STAT3—Disease—GOT1—liver cancer	5.06e-05	0.000327	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PRKCE—liver cancer	5.05e-05	0.000326	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GGT1—liver cancer	5.03e-05	0.000325	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	5.02e-05	0.000324	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—AKT1—liver cancer	5.01e-05	0.000324	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—TP53—liver cancer	4.87e-05	0.000314	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ABL1—liver cancer	4.81e-05	0.000311	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—PIK3CA—liver cancer	4.8e-05	0.00031	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—PIK3CA—liver cancer	4.72e-05	0.000305	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP2E1—liver cancer	4.68e-05	0.000302	CbGpPWpGaD
Niclosamide—STAT3—Disease—PRKCE—liver cancer	4.66e-05	0.000301	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	4.62e-05	0.000298	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	4.53e-05	0.000292	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HGF—liver cancer	4.52e-05	0.000292	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTP1—liver cancer	4.52e-05	0.000292	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ADAM17—liver cancer	4.48e-05	0.00029	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD8A—liver cancer	4.47e-05	0.000289	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CSF2—liver cancer	4.47e-05	0.000289	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	4.46e-05	0.000288	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—IL6—liver cancer	4.46e-05	0.000288	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HRAS—liver cancer	4.44e-05	0.000287	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—CTNNB1—liver cancer	4.43e-05	0.000286	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—HRAS—liver cancer	4.37e-05	0.000282	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP9—liver cancer	4.35e-05	0.000281	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GGT1—liver cancer	4.3e-05	0.000278	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL6—liver cancer	4.25e-05	0.000275	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PSMA4—liver cancer	4.22e-05	0.000272	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PSMD10—liver cancer	4.22e-05	0.000272	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—IL6—liver cancer	4.18e-05	0.00027	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	4.16e-05	0.000269	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	4.15e-05	0.000268	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTM1—liver cancer	4.15e-05	0.000268	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	4.09e-05	0.000265	CbGpPWpGaD
Niclosamide—STAT3—Disease—H2AFX—liver cancer	4.07e-05	0.000263	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	4e-05	0.000259	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP1A1—liver cancer	3.94e-05	0.000254	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—VEGFA—liver cancer	3.9e-05	0.000252	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	3.88e-05	0.000251	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	3.88e-05	0.000251	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	3.88e-05	0.000251	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	3.86e-05	0.000249	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTP1—liver cancer	3.86e-05	0.000249	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—AKT1—liver cancer	3.86e-05	0.000249	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	3.85e-05	0.000249	CbGpPWpGaD
Niclosamide—STAT3—Immune System—BCL2L1—liver cancer	3.82e-05	0.000247	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	3.81e-05	0.000246	CbGpPWpGaD
Niclosamide—STAT3—Disease—MTHFR—liver cancer	3.69e-05	0.000238	CbGpPWpGaD
Niclosamide—STAT3—Disease—TERT—liver cancer	3.68e-05	0.000238	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MAPK14—liver cancer	3.62e-05	0.000234	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TGFB1—liver cancer	3.58e-05	0.000231	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTM1—liver cancer	3.55e-05	0.000229	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	3.5e-05	0.000226	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	3.42e-05	0.000221	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP1A1—liver cancer	3.36e-05	0.000217	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TNF—liver cancer	3.34e-05	0.000216	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	3.32e-05	0.000214	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—KRAS—liver cancer	3.32e-05	0.000214	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	3.3e-05	0.000213	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	3.27e-05	0.000211	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PRKCE—liver cancer	3.27e-05	0.000211	CbGpPWpGaD
Niclosamide—STAT3—Disease—APC—liver cancer	3.1e-05	0.0002	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IGF2—liver cancer	3.09e-05	0.0002	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CDH1—liver cancer	3.09e-05	0.0002	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	2.95e-05	0.000191	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PIK3CD—liver cancer	2.95e-05	0.000191	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—UGDH—liver cancer	2.94e-05	0.00019	CbGpPWpGaD
Niclosamide—STAT3—Disease—BRAF—liver cancer	2.91e-05	0.000188	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CSF2—liver cancer	2.89e-05	0.000187	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—H2AFX—liver cancer	2.85e-05	0.000184	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—HRAS—liver cancer	2.82e-05	0.000182	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—EPT1—liver cancer	2.77e-05	0.000179	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3CD—liver cancer	2.72e-05	0.000176	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IL6—liver cancer	2.7e-05	0.000174	CbGpPWpGaD
Niclosamide—STAT3—Disease—SERPINE1—liver cancer	2.69e-05	0.000174	CbGpPWpGaD
Niclosamide—STAT3—Immune System—RAF1—liver cancer	2.63e-05	0.00017	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—TAT—liver cancer	2.62e-05	0.00017	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	2.58e-05	0.000167	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TERT—liver cancer	2.58e-05	0.000166	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MTOR—liver cancer	2.57e-05	0.000166	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PIK3CB—liver cancer	2.57e-05	0.000166	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	2.52e-05	0.000163	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—UGDH—liver cancer	2.52e-05	0.000163	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—AKT1—liver cancer	2.49e-05	0.000161	CbGpPWpGaD
Niclosamide—STAT3—Disease—RAF1—liver cancer	2.43e-05	0.000157	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CDKN1B—liver cancer	2.41e-05	0.000156	CbGpPWpGaD
Niclosamide—STAT3—Disease—MTOR—liver cancer	2.37e-05	0.000153	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3CB—liver cancer	2.37e-05	0.000153	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—EPT1—liver cancer	2.37e-05	0.000153	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL2—liver cancer	2.36e-05	0.000153	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KDR—liver cancer	2.36e-05	0.000152	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MAPK14—liver cancer	2.34e-05	0.000151	CbGpPWpGaD
Niclosamide—STAT3—Immune System—JUN—liver cancer	2.3e-05	0.000148	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ESR1—liver cancer	2.3e-05	0.000148	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CTNNB1—liver cancer	2.28e-05	0.000147	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—F2—liver cancer	2.27e-05	0.000146	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—TAT—liver cancer	2.24e-05	0.000145	CbGpPWpGaD
Niclosamide—STAT3—Disease—CDKN1B—liver cancer	2.23e-05	0.000144	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CDKN1A—liver cancer	2.23e-05	0.000144	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	2.21e-05	0.000142	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MAPK8—liver cancer	2.17e-05	0.00014	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APC—liver cancer	2.17e-05	0.00014	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CG—liver cancer	2.17e-05	0.00014	CbGpPWpGaD
Niclosamide—STAT3—Disease—CTNNB1—liver cancer	2.11e-05	0.000136	CbGpPWpGaD
Niclosamide—STAT3—Disease—CDKN1A—liver cancer	2.06e-05	0.000133	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—BRAF—liver cancer	2.04e-05	0.000132	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.93e-05	0.000125	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CD—liver cancer	1.91e-05	0.000123	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SERPINE1—liver cancer	1.89e-05	0.000122	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GLUL—liver cancer	1.78e-05	0.000115	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CPT1B—liver cancer	1.78e-05	0.000115	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NR1H4—liver cancer	1.72e-05	0.000111	CbGpPWpGaD
Niclosamide—STAT3—Immune System—KRAS—liver cancer	1.71e-05	0.00011	CbGpPWpGaD
Niclosamide—STAT3—Disease—MYC—liver cancer	1.71e-05	0.00011	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—RAF1—liver cancer	1.7e-05	0.00011	CbGpPWpGaD
Niclosamide—STAT3—Disease—TGFB1—liver cancer	1.7e-05	0.00011	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTA3—liver cancer	1.69e-05	0.000109	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MTOR—liver cancer	1.66e-05	0.000107	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CB—liver cancer	1.66e-05	0.000107	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.65e-05	0.000107	CbGpPWpGaD
Niclosamide—STAT3—Disease—KRAS—liver cancer	1.58e-05	0.000102	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PIK3CA—liver cancer	1.57e-05	0.000101	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CDKN1B—liver cancer	1.56e-05	0.000101	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTA4—liver cancer	1.55e-05	9.99e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CASP3—liver cancer	1.53e-05	9.88e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL2—liver cancer	1.53e-05	9.86e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CPT1B—liver cancer	1.52e-05	9.85e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GLUL—liver cancer	1.52e-05	9.85e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.51e-05	9.76e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTA2—liver cancer	1.51e-05	9.74e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCND1—liver cancer	1.49e-05	9.62e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—JUN—liver cancer	1.49e-05	9.6e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CTNNB1—liver cancer	1.47e-05	9.52e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NR1H4—liver cancer	1.47e-05	9.49e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTA1—liver cancer	1.45e-05	9.39e-05	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HRAS—liver cancer	1.45e-05	9.37e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3CA—liver cancer	1.45e-05	9.35e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MMP9—liver cancer	1.45e-05	9.34e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTA3—liver cancer	1.44e-05	9.33e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CDKN1A—liver cancer	1.44e-05	9.3e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NAT2—liver cancer	1.44e-05	9.29e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MAPK8—liver cancer	1.41e-05	9.08e-05	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL6—liver cancer	1.39e-05	8.97e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.38e-05	8.93e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALDOB—liver cancer	1.38e-05	8.9e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—HRAS—liver cancer	1.34e-05	8.65e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTA4—liver cancer	1.32e-05	8.54e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CRABP1—liver cancer	1.31e-05	8.49e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—VEGFA—liver cancer	1.3e-05	8.38e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.29e-05	8.34e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTA2—liver cancer	1.29e-05	8.32e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL6—liver cancer	1.28e-05	8.28e-05	CbGpPWpGaD
Niclosamide—STAT3—Immune System—AKT1—liver cancer	1.28e-05	8.27e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTA1—liver cancer	1.24e-05	8.03e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NAT2—liver cancer	1.23e-05	7.94e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MYC—liver cancer	1.19e-05	7.71e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TGFB1—liver cancer	1.19e-05	7.69e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.18e-05	7.65e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKT1—liver cancer	1.18e-05	7.64e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.18e-05	7.63e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALDOB—liver cancer	1.18e-05	7.61e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HPGDS—liver cancer	1.15e-05	7.42e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.14e-05	7.38e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CRABP1—liver cancer	1.12e-05	7.26e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KRAS—liver cancer	1.1e-05	7.13e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.04e-05	6.72e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.03e-05	6.64e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PSMD10—liver cancer	1.02e-05	6.62e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PSMA4—liver cancer	1.02e-05	6.62e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CA—liver cancer	1.01e-05	6.55e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.01e-05	6.54e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GOT2—liver cancer	9.97e-06	6.44e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HPGDS—liver cancer	9.82e-06	6.34e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TP53—liver cancer	9.81e-06	6.33e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.76e-06	6.31e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HRAS—liver cancer	9.38e-06	6.06e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP2E1—liver cancer	9.37e-06	6.05e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.07e-06	5.86e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL6—liver cancer	8.98e-06	5.8e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.89e-06	5.75e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.78e-06	5.67e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYCS—liver cancer	8.77e-06	5.66e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PSMD10—liver cancer	8.75e-06	5.66e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PSMA4—liver cancer	8.75e-06	5.66e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GOT1—liver cancer	8.6e-06	5.56e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GGT1—liver cancer	8.6e-06	5.56e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GOT2—liver cancer	8.52e-06	5.5e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKT1—liver cancer	8.28e-06	5.35e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP2E1—liver cancer	8.01e-06	5.17e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.75e-06	5.01e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTP1—liver cancer	7.73e-06	4.99e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HMOX1—liver cancer	7.62e-06	4.92e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYCS—liver cancer	7.49e-06	4.84e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GGT1—liver cancer	7.35e-06	4.75e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GOT1—liver cancer	7.35e-06	4.75e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTM1—liver cancer	7.1e-06	4.59e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP1A1—liver cancer	6.73e-06	4.35e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTP1—liver cancer	6.6e-06	4.27e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HMOX1—liver cancer	6.51e-06	4.21e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—MTHFR—liver cancer	6.28e-06	4.05e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPARA—liver cancer	6.16e-06	3.98e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTM1—liver cancer	6.07e-06	3.92e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP1A1—liver cancer	5.75e-06	3.72e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.53e-06	3.57e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—MTHFR—liver cancer	5.36e-06	3.46e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CG—liver cancer	5.27e-06	3.41e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPARA—liver cancer	5.26e-06	3.4e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPARG—liver cancer	5.09e-06	3.29e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.73e-06	3.05e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CD—liver cancer	4.63e-06	2.99e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALB—liver cancer	4.58e-06	2.96e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CG—liver cancer	4.51e-06	2.91e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPARG—liver cancer	4.35e-06	2.81e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CB—liver cancer	4.04e-06	2.61e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CD—liver cancer	3.96e-06	2.56e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALB—liver cancer	3.91e-06	2.53e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CB—liver cancer	3.45e-06	2.23e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CA—liver cancer	2.46e-06	1.59e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CA—liver cancer	2.1e-06	1.36e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKT1—liver cancer	2.01e-06	1.3e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKT1—liver cancer	1.72e-06	1.11e-05	CbGpPWpGaD
